Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 30.01.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
30.01.Tele2 AB: Tele2 reports full year and fourth quarter 2023 results1Stockholm - Tele2 AB ("Tele2") (Nasdaq Stockholm: TEL2 A and TEL2 B) today announces its consolidated results for the full year and fourth quarter 2023.Highlights End-user service revenue of SEK...
► Artikel lesen
30.01.Arjo AB: Arjo's year-end report January-December 202332"We are ending 2023 with healthy growth, significantly improved earnings and strong operating cash flow. During the year considerable focus was put on profitable growth in a market characterized by...
► Artikel lesen
30.01.RVRC Holding AB: RevolutionRace continues to deliver solid growth and profitability38Financial development & significant events during the second quarter (1 Oct - 31 Dec)Net sales for the period increased by 21 percent and amounted to SEK 613 (509) million.Gross profit amounted to SEK...
► Artikel lesen
30.01.Kesko Oyj: Kesko's financial statements release 1 Jan. -31 Dec. 2023: A good result from all divisions126KESKO CORPORATION JANUARY-DECEMBER FINANCIAL STATEMENTS RELEASE 30.1.2024 AT 8.00 FINANCIAL PERFORMANCE IN BRIEF: 10-12/2023 Group net sales in October-December totalled €2,902.0 million (€2,983.4...
► Artikel lesen
30.01.Nordic Paper Holding AB: Nordic Paper year-end report January-December 2023223QUARTERLY RESULTS OCTOBER - DECEMBER Net sales amounted to SEK 971 m (1,206 m), a decrease of 20% compared with the same quarter the previous year. Excluding currency effects, net sales decreased...
► Artikel lesen
30.01.Invitae Corporation: Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics278SAN FRANCISCO, Jan. 30, 2024 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced a partnership with BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage...
► Artikel lesen
30.01.Nuvei launches ERP integration with Microsoft Dynamics 365101Dynamics 365 Business Central customers can now elevate their accounting workflow and payments leveraging Nuvei's B2B technology embedded directly into their ERP MONTREAL, Jan. 30 2024 /CNW/ --...
► Artikel lesen
30.01.PREDICTIVE DISCOVERY LIMITED: Sounsoun, SB and SEB Targets Advanced by Latest Drilling-
30.01.JUNO MINERALS LIMITED: Mount Ida Lithium Prospect - Phase 2 Exploration Update-
30.01.UVRE LIMITED: Investor Presentation - February 2024-
30.01.KIN MINING NL: Investor Presentation - Resource Rising Stars-
30.01.LITTLE GREEN PHARMA LTD: LGP receives $5 million R&D rebate-
30.01.NANOVEU LIMITED: Notification regarding unquoted securities - NVU-
30.01.NANOVEU LIMITED: Application for quotation of securities - NVU-
30.01.NEX METALS EXPLORATION LIMITED: Wardens Court Decision - Yundramindra-
30.01.MITCHELL SERVICES LIMITED: Update - Notification of buy-back - MSV-
30.01.MELBANA ENERGY LIMITED: Alameda 3 Drilling Update-
30.01.PWR HOLDINGS LIMITED: Initial Director's Interest Notice - Kristen Podagiel-
30.01.CLIME CAPITAL LIMITED: Update - Notification of buy-back - CAM-
30.01.SINGULAR HEALTH GROUP LTD: First Enterprise Sale in United States Medical Education-
Seite:  Weiter >>